M
MYR
Biotech & Life Sciences · Bad Homburg, Germany · Founded 2011
Biotech company developing and commercialising novel therapies for chronic hepatitis D MoreLess
MYR GmbH, a subsidiary of Gilead Sciences, Inc., is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for areas with significant unmet medical needs. The company operates in the global healthcare market, providing advanced therapeutic solutions to patients with life-threatening illnesses. MYR GmbH primarily serves healthcare providers, hospitals, and patients, leveraging its research and development capabilities to bring new treatments to market. The business model revolves around the development and commercialization of proprietary drugs, generating revenue through the sale of these medicines. By focusing on innovation and patient care, MYR GmbH aims to transform and simplify medical treatment for severe health conditions.
Keywords: biopharmaceutical, innovative medicines, unmet medical needs, global healthcare, therapeutic solutions, research and development, proprietary drugs, patient care, life-threatening illnesses, commercialization.
Talent graph
MYR's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where MYR has talent and traffic
across markets
Patent intelligence
$4M patent portfolio · 2 active families
Where MYR concentrates vs peers
Each axis is a top-10 topic across MYR and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about MYR
An AI-synthesized read of the highest-engagement posts about MYR on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MYR on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.